SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001447028-21-000062
Filing Date
2021-11-12
Accepted
2021-11-12 06:17:45
Documents
2
Period of Report
2021-11-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_163671585109918.html 3  
1 FORM 3 wf-form3_163671585109918.xml 3 1723
2 POWER OF ATTORNEY poa-tran.htm EX-24 3322
  Complete submission text file 0001447028-21-000062.txt   6590
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ARBUTUS BIOPHARMA CORPORATION 701 VETERANS CIRCLE WARMINSTER PA 18974
Business Address
Tran Tram (Reporting) CIK: 0001892918 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 211399114